An 84-year-old Caucasian female was transferred from an emergency department to a frailty assessment unit following a fall and fracturing her right distal femur. She had bilateral lower leg swelling, pain and erythema ( Figure 1 ). In the emergency department she had been started on fl ucloxacillin for bilateral cellulitis. However, the blood results showed no evidence of active infection. Following the comprehensive geriatric assessment the antibiotics were stopped and the patient's condition was diagnosed as lipodermatosclerosis. Lipodermatosclerosis is a term used to describe skin changes in the lower legs as a consequence of venous insuffi ciency and venous stasis. It typically presents with redness, swelling, increased pigmentation and skin induration with an inverted champagne bottle appearance.¹ It can present as an acute or chronic condition (Table 1) .¹ Venous eczema is a common presentation in the elderly, affecting around 20% of people of people above the age of 70 years. A total of 10% of people with varicose veins go on to develop skin changes.² The pathophysiology of lipodermatosclerosis is not completely understood; however, it is thought that it is related to venous hypertension, venous incompetence and obesity. Venous incompetence leads to extravasation of intravascular fl uid, depriving tissues and cells of oxygen. The damaged tissue causes microthrombi formation and infarction, eventually leading fi broblasts to form granulation tissue.³ Diagnosis is usually made clinically, in the absence of routine skin biopsies. Cellulitis accounts for approximately 2-3% of all hospital admissions (with lower limb cellulitis being most prevalent). 4 In our experience in the clinical environment, lipodermatosclerosis is often treated as cellulitis owing to similarities between the conditions. An estimated 10% of people treated for cellulitis do not have it, leading to incorrect use of antibiotics and delaying the correct treatment. Features of acute lipodermatosclerosis can resemble cellulitis.³
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Other management options include vein surgery, such as sclerotherapy and laser ablation; ultrasound therapy; fibrinolytic agents, such as stanozolol; pentoxifylline to improve blood fl ow; topical agents, such as corticosteroids; and analgesia, such as capsaicin, to reduce pain.¹
